Drug
Lactium
Lactium is a pharmaceutical drug with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
3
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Active(2)
Completed(1)
Detailed Status
Not yet recruiting2
Completed1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
not_yet_recruiting267%
completed133%
Recent Activity
0 active trials
Showing 3 of 3
completednot_applicable
Preemptive Oral Lactium to Prevent Emergence Agitation
NCT07172594
not_yet_recruitingnot_applicable
The Effect of Non Invasive Stellate Ganglion Disrupting on Sleep Disturbances on Postmenopausal Female
NCT07224295
not_yet_recruitingnot_applicable
Effect of Lactium on Sleep Disorders in Healthy Volunteers With Persistent Subclinical Insomnia
NCT06378034
Clinical Trials (3)
Showing 3 of 3 trials
NCT07172594Not Applicable
Preemptive Oral Lactium to Prevent Emergence Agitation
NCT07224295Not Applicable
The Effect of Non Invasive Stellate Ganglion Disrupting on Sleep Disturbances on Postmenopausal Female
NCT06378034Not Applicable
Effect of Lactium on Sleep Disorders in Healthy Volunteers With Persistent Subclinical Insomnia
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3